Forward for Specialty Finance
Deal Summary
Rocket Pharmaceuticals
$150,000,000
Term loan facility: $35 million at closing, $35 million optional, $30 million on clinical milestone, $50 million subject to investment committee approval
Hercules Capital
Deal Notes:
30-month interest-only period, 48-month maturity; includes warrants; supports Phase 2 study of RP-A501
